Cyclooxygenases: new forms, new inhibitors, and lessons from the clinic

By T. Warner, J. Mitchell. The FASEB Journal, 2004

658 citations recorded by the source corpus.

Subfields: Biochemistry, Genetics, Pharmacology

View Paper: https://www.semanticscholar.org/paper/a9ca852690fddfe76c25370f0d738a9dec9e39b8

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Biochemistry

1. L. Lindmark
2. R. Grzanna
3. C. Frondoza

In Genetics

1. L. Lindmark
2. R. Grzanna
3. C. Frondoza

In Pharmacology

1. L. Lindmark
2. R. Grzanna
3. C. Frondoza

Citations in the corpus

• Selective COX-1 inhibition: A therapeutic target to be reconsidered. (2010, background): “On the contrary, under pathological conditions, such as inflammation or atherosclerosis, the PGI2 production decreases, and COX-derived vasoconstrictor substance release, including TXA2, becomes predominant [56].”
• Ginger—An Herbal Medicinal Product with Broad Anti-Inflammatory Actions (2005, positive): “25 So far, only one study has attempted to determine the relative potency of gingerols on COX enzyme activity in intact cells.”